# C_2014185EN.01004601.xml

| 17.6.2014 | EN | Official Journal of the European Union | C 185/46 |
| --- | --- | --- | --- |

17.6.2014

EN

Official Journal of the European Union

C 185/46

---

Prior notification of a concentration

(Case M.7294 — Carlyle / Haier Group / Haier Biomedical and Laboratory Product)

Candidate case for simplified procedure

(Text with EEA relevance)

(2014/C 185/11)

| 1. | On 6 June 2014 the European Commission received a notification of a proposed concentration according to Article 4 Council Regulation (EC) No 139/2004 (1) by which the Carlyle Group L.P. (‘Carlyle’, USA) and Haier Group Corporation (‘Haier Group’, China) intend to acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking Haier Biomedical and Laboratory Products Co., Ltd (‘HBML’, China), currently solely controlled by the Haier Group. |
| --- | --- |

1.

On 6 June 2014 the European Commission received a notification of a proposed concentration according to Article 4 Council Regulation (EC) No 139/2004 (1) by which the Carlyle Group L.P. (‘Carlyle’, USA) and Haier Group Corporation (‘Haier Group’, China) intend to acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking Haier Biomedical and Laboratory Products Co., Ltd (‘HBML’, China), currently solely controlled by the Haier Group.

1

| 2. | The business activities of the undertakings concerned are:
  —   for Carlyle: global alternative asset manager,
  —   for Haier Group: multinational manufacturer and supplier of consumer electronics and home appliances,
  —   for HBML: supplier of general laboratory equipment, in particular medical freezers, medical fridges/deep freezers and biomedical safety hoods. |
| --- | --- |

2.

The business activities of the undertakings concerned are:

—   for Carlyle: global alternative asset manager,

for Carlyle

—   for Haier Group: multinational manufacturer and supplier of consumer electronics and home appliances,

for Haier Group

—   for HBML: supplier of general laboratory equipment, in particular medical freezers, medical fridges/deep freezers and biomedical safety hoods.

for HBML

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

2

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7294 — Carlyle / Haier Group / Haier Biomedical and Laboratory Product, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition, |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7294 — Carlyle / Haier Group / Haier Biomedical and Laboratory Product, to the following address:

European Commission

Directorate-General for Competition,

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---